Melanoma CME

This activity is expired and is no longer available for CME credit.


Adjuvant Therapy for High-Risk Melanoma

Author(s)/Faculty: Ahmad Tarhini, MD, PhD
Release Date: 3/28/2016Expiration Date: 3/27/2017
Credit Type: CMENumber of Credits: 0
Content Type: ArticleProvider:
Systemic adjuvant therapy targets melanoma micrometastases in patients who continue to carry a high risk of death from recurrence after surgical treatment alone. This CME activity will explore the role of adjuvant therapy in patients with melanoma.